Average Co-Inventor Count = 6.15
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. G.d. Searle & Company (18 from 1,323 patents)
2. Other (6 from 832,891 patents)
3. Monsanto Company (2 from 3,288 patents)
4. Washington University (2 from 1,586 patents)
5. Pharmacia Corporation (1 from 220 patents)
6. G.d. Searle LLC (1 from 33 patents)
7. Baxter Biotech Technology Sarl (1 from 13 patents)
31 patents:
1. 7091319 - IL-3 variant hematopoiesis fusion protein
2. 6479261 - Methods of using interleukin-3 (IL-3) mutant polypeptides for ex-vivo expansion of hematopoietic stem cells
3. 6458931 - Interleukin-3 (IL-3) multiple mutation polypeptides
4. 6440407 - Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 (IL-3) multiple mutation polypeptides
5. 6436387 - Methods of ex-vivo expansion of hematopoietic cells using multivariant IL-3 hematopoiesis chimera proteins
6. 6413509 - Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 mutant polypeptides with other hematopoietic growth factors
7. 6361976 - Co-administration of interleukin-3 mutant polypeptides with CSF'S for multi-lineage hematopoietic cell production
8. 6361977 - Methods of using multivariant IL-3 hematopoiesis fusion protein
9. 6218513 - Globins containing binding domains
10. 6153183 - Co-administration of interleukin-3 mutant polypeptides with CSF's or
11. 6132991 - Human interleukin-3 (IL-3) variant fusion proteins
12. 6093395 - Co-administration of interleukin-3 mutant polypeptides with CSF's for
13. 6074639 - Ex vivo expansion of hematopoietic cells using interleukin-3 (IL-3)
14. 6060047 - Co-administration of interleukin-3 mutant polypeptides with CSF's for
15. 6057133 - Multivariant human IL-3 fusion proteins and their recombinant production